Myriad Genetics Reveals New Data on Precise MRD Sensitivity
June 2, 2025
MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one month after surgery had tumor